Search for: "U. S. v. Morgan" Results 1 - 20 of 98
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jul 2007, 7:50 am
His lifetime of public service culminated in his appointment as U. [read post]
20 Apr 2012, 5:10 am by Jamison Koehler
Court of Appeals dealt with in an opinion it issued last week, Morgan v. [read post]
24 Jul 2018, 4:20 am by Andrew Lavoott Bluestone
“This action originated from Defendant Sack’s representation of PlaintiffReches in an underlying mediation with Plaintiffs employer, Morgan Stanley (“Morgan Stanley”) on June 18, 2014. [read post]
21 Sep 2018, 4:17 am by Andrew Lavoott Bluestone
Conway also avers that he provided plaintiffs with language with which they could respond to Morgan Stanley’s allegations on the U-5’s, but that plaintiffs chose not to respond. [read post]
3 Sep 2010, 11:42 am by FDABlog HPM
Karst –       A recent report issued by Morgan Stanley, titled Pharmaceuticals - Potential Selective Upside for Industry post Prandin Ruling, predicts “increasing probability for the innovative pharmaceutical industry to successfully delay US generic approval of select innovative drugs” following a pair of rulings (here and here) in Novo Nordisk A/S v. [read post]